Project Grant U9055832
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $1.3M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
- The Health Resources and Services Administration HIV/AIDS Bureau awarded Emory University $3.24 million on September 1, 2026, under the Special Projects of National Significance program (CFDA 93.928) to serve as implementation technical assistance provider for the REACH Men initiative. REACH Men will deliver intensive technical assistance, organizational development support, implementation coaching, continuous quality improvement, and peer learning to eight Ryan White HIV/AIDS Program-funded...
- The Health Resources and Services Administration awarded the Missouri Department of Health & Senior Services $4.312 million under the HIV Care Formula Grants program (CFDA 93.917) on September 30, 2025, to expand comprehensive medical care and support services for low-income individuals living with HIV across Missouri. The award funds a coordinated system of care that includes primary medical care, oral health, mental health and substance use treatment, and medication through the AIDS Drug...
- The Department of Health and Human Services Health Resources and Services Administration awarded $8,089,379 to the Missouri Department of Health & Senior Services on April 1, 2026, under the HIV Care Formula Grants program (CFDA 93.917) to relieve ADAP shortfall and ensure access to HIV medications and comprehensive medical care for low-income individuals living with HIV in Missouri. The award funds Missouri's coordinated system of care, which integrates HIV medication access through the...
- This Project Grant award of $786,954 from the U.S. Department of Health and Human Services' Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program aims to understand the timing and patterns of treatment-seeking among marginalized rape survivors. The primary awardee, the University of Missouri at Kansas City (UMKC), will recruit a large, diverse sample of mostly marginalized, mostly women rape survivors and follow them for years to observe naturalistic screening practices and...
- The National Institutes of Health Office of the Director awarded Fred Hutchinson Cancer Center $1,000,792 on September 12, 2025, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial testing telehealth-supported delivery of HIV pre- and post-exposure prophylaxis (PrEP and PEP) at private pharmacies in Kenya. The study will randomize 20 pharmacies across Kisumu and Homa Bay Counties in Western Kenya...
- The Substance Abuse and Mental Health Services Administration awarded $800,000 to KC Care Health Center on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to implement the Kansas City Zero Suicide Initiative. KC Care Health Center will deploy standardized suicide risk screening using the PHQ-9 and Columbia Suicide Severity Rating Scale, workforce training, Collaborative Assessment and Management of Suicidality...
- The National Institute of Mental Health awarded $812,484 to The Trustees of the University of Pennsylvania on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to test the effectiveness and dissemination of a digital intervention promoting home HIV testing and linkage to PrEP among men who have sex with men in Philadelphia. The project will randomize approximately 1,000 MSM participants to an experimental arm receiving tailored social-media and SMS messages...
- The National Institute of Allergy and Infectious Diseases awarded The Washington University $777,756 on June 18, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct Research on End-User Acceptability and Long-Term Impacts of HIV Cure Strategies (REALISE). The project delivers three integrated research aims. Aim 1 conducts qualitative interviews with approximately 30 researchers and developers to define plausible 10–20-year HIV cure and long-acting...
- The Centers for Disease Control and Prevention awarded Houston Department of Health and Human Services a $1.463690 million cooperative agreement on September 30, 2025, to implement the Medical Monitoring Project in Houston and Harris County, Texas, under CFDA 93.940 (HIV Prevention and Surveillance Activities—Health Department Based). The Medical Monitoring Project is a key component of the National HIV Surveillance System designed to inform local and national HIV prevention and treatment...
- The Substance Abuse and Mental Health Services Administration awarded the Missouri Department of Mental Health $2 million on September 30, 2026, under the Center for Substance Abuse Prevention Projects of Regional and National Significance program (CFDA 93.492) to implement a statewide Strategic Prevention Framework initiative addressing youth substance use. Missouri will establish a coordinated system of Prevention Resource Centers and community coalitions to build prevention infrastructure...